Mazumdar-Shaw on Biocon’s Mission to Make Life-Saving Drugs Accessible

Hello. If you want to show more patience, then it's about economies of scale, high volume. And if you want to sell a few patience, it's about high value, low volume.So you decide. I've chosen the format because I want to serve more patients in the high stakes world of pharmaceuticals. Global giants like Eli Lilly, Sanofi, and Novo Nordisk have dominated the spotlight.But India has been quietly building a powerhouse in one of medicine's fastest growing sectors. Biosimilars. Biocon is at the forefront of ther ...